ACT Biotech (Molecule Drug Assets) is Drug Discovery in United States that focus on developer business. They cover business area such as developer, molecule drug, cancer.
-
Developer
-
c/o NGN Capital, 369 Lexington Avenue
17th floor
New York, NY 10017
United States
Private
developermolecule drugcancer
* We use standard office opening hours in near ACT Biotech (Molecule Drug Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ACT Biotech (Molecule Drug Assets) is Drug Discovery business from United States that founded in - ( years old in ), ACT Biotech (Molecule Drug Assets) business is focusing on Developer.
ACT Biotech (Molecule Drug Assets) headquarter office and corporate office address is located in c/o NGN Capital, 369 Lexington Avenue 17th floor New York, NY 10017 United States.
ACT Biotech (Molecule Drug Assets) was founded in United States.
In , ACT Biotech (Molecule Drug Assets) is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ACT Biotech (Molecule Drug Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
